Reflecting on the various mechanisms of modulating the cGAS-STING pathway in oncology, it is important to realize that in many tissues, the level of STING expression is low, especially in most normal brain cells and human glioblastoma cells (a classic example of an immunologically cold tumor). This evidence concerns the gene STING1 and neoplasm.